Israeli COVID-19 Candidate Vaccine Gets Crowdfunding Support
$12m Financing Will Advance Migal Institute’s Investigational Jab
Executive Summary
Crowd-funding venture capital platform OurCrowd is leading a $12m investment in the newly formed MigVax Corp to fund development of a potential COVID-19 vaccine whose discovery was a by-product of an avian virus vaccine researchers were already working on for the poultry industry.